Standard Biotools (LAB) Share-based Compensation Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -4.08% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 12.94% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 26.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 59.09% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 31.63% |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn | 9.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.63% |
| Dec 31, 2025 | -76.04% |
| Sep 30, 2025 | 62.10% |
| Jun 30, 2025 | 57.54% |
| Mar 31, 2025 | -30.68% |
| Dec 31, 2024 | 478.56% |
| Sep 30, 2024 | 37.30% |
| Jun 30, 2024 | 9.51% |
| Mar 31, 2024 | 268.84% |
| Dec 31, 2023 | 106.72% |
| Sep 30, 2023 | -24.66% |
| Jun 30, 2023 | -33.22% |
| Mar 31, 2023 | -22.12% |
| Sep 30, 2022 | -61.71% |
| Jun 30, 2022 | -37.14% |
| Mar 31, 2022 | 9.93% |
| Sep 30, 2021 | 169.34% |
| Jun 30, 2021 | 104.13% |
| Mar 31, 2021 | 55.41% |
| Dec 31, 2020 | 31.99% |
| Sep 30, 2020 | 43.88% |
| Jun 30, 2020 | 21.46% |
| Mar 31, 2020 | 4.18% |
| Dec 31, 2019 | -37.56% |
| Sep 30, 2019 | 31.52% |
| Jun 30, 2019 | 49.08% |
| Mar 31, 2019 | 29.99% |
| Dec 31, 2018 | 148.92% |
| Sep 30, 2018 | -0.82% |
| Jun 30, 2018 | -13.83% |
| Mar 31, 2018 | -28.58% |
| Dec 31, 2017 | -29.38% |
| Sep 30, 2017 | -35.25% |
| Jun 30, 2017 | -37.56% |
| Mar 31, 2017 | -34.19% |
| Dec 31, 2016 | -28.48% |
| Sep 30, 2016 | -13.47% |
| Jun 30, 2016 | -19.58% |
| Mar 31, 2016 | -8.63% |
| Dec 31, 2015 | -78.41% |
| Mar 31, 2015 | 53.63% |
| Dec 31, 2014 | 941.09% |
| Dec 31, 2013 | 68.78% |
| Sep 30, 2013 | 368.10% |
| Jun 30, 2013 | 54.55% |
| Dec 31, 2012 | 30.29% |
| Sep 30, 2012 | 42.86% |
| Jun 30, 2012 | 120.00% |
| Mar 31, 2012 | 13.92% |
| Dec 31, 2011 | 149.69% |
| Sep 30, 2011 | 66.67% |